Directed/JJ
Causal/JJ
Network/NN
Construction/NN
Using/VBG
Linkage/JJ
Analysis/NN
with/IN
Metabolic/JJ
Syndrome-Related/JJ
Expression/NN
Quantitative/JJ
Traits/NNS
./.
====================
In/IN
this/DT
study/NN
,/,
we/PRP
propose/VBP
a/DT
novel/JJ
,/,
intuitive/JJ
method/NN
of/IN
constructing/VBG
an/DT
expression/NN
quantitative/JJ
trait/NN
(/(
eQT/JJ
)/)
network/NN
that/IN
is/VBZ
related/JJ
to/TO
the/DT
metabolic/JJ
syndrome/NN
using/VBG
LOD/NN
scores/VBZ
and/CC
peak/NN
loci/NNS
for/IN
selected/VBN
eQTs/NNS
,/,
based/VBN
on/IN
the/DT
concept/NN
of/IN
gene-gene/JJ
interactions/NNS
./.
====================
We/PRP
selected/VBD
49/CD
eQTs/NNS
that/DT
were/VBD
related/JJ
to/TO
insulin/NN
resistance/NN
./.
====================
A/DT
variance/NN
component/NN
linkage/NN
analysis/NN
was/VBD
performed/VBN
to/TO
explore/VB
the/DT
expression/NN
loci/NNS
of/IN
each/DT
of/IN
the/DT
eQTs/NNS
./.
====================
The/DT
linkage/NN
peak/NN
loci/NNS
were/VBD
investigated/VBN
,/,
and/CC
the/DT
``/NN
support/VBP
zone/NN
''/CD
was/VBD
defined/VBN
within/IN
boundaries/NNS
of/IN
an/DT
LOD/NN
score/RB
of/IN
0.5/CD
from/IN
the/DT
peak/NN
./.
====================
If/IN
one/CD
gene/NN
was/VBD
located/JJ
within/IN
the/DT
``/NN
support/VBP
zone/NN
''/CD
of/IN
the/DT
peak/NN
loci/NNS
for/IN
the/DT
eQT/JJ
of/IN
another/DT
gene/NN
,/,
the/DT
relationship/NN
was/VBD
considered/VBN
as/IN
a/DT
potential/JJ
``/JJ
directed/VBN
causal/JJ
pathway/NN
''/CD
from/IN
the/DT
former/JJ
to/TO
the/DT
latter/JJ
gene/NN
./.
====================
SNP/NN
markers/NNS
under/IN
the/DT
linkage/NN
peaks/VBZ
or/CC
within/IN
the/DT
support/NN
zone/NN
were/VBD
searched/VBN
for/IN
in/IN
the/DT
database/NN
to/TO
identify/VB
the/DT
genes/NNS
at/IN
the/DT
loci/NNS
./.
====================
Two/CD
groups/NNS
of/IN
gene/NN
networks/NNS
were/VBD
formed/VBN
separately/RB
around/IN
the/DT
genes/NNS
IRS2/NN
and/CC
UGCGL2/NN
./.
====================
The/DT
findings/NNS
indicated/VBD
evidence/NN
of/IN
networks/NNS
between/IN
genes/NNS
that/WDT
were/VBD
related/JJ
to/TO
the/DT
metabolic/JJ
syndrome/NN
./.
====================
The/DT
use/NN
of/IN
linkage/NN
analysis/NN
enabled/VBD
the/DT
construction/NN
of/IN
directed/VBN
causal/JJ
networks/NNS
./.
====================
This/DT
methodology/NN
showed/VBD
that/IN
characterizing/VBG
and/CC
locating/JJ
eQTs/NNS
can/MD
provide/VB
an/DT
effective/JJ
means/NNS
of/IN
constructing/VBG
a/DT
genetic/JJ
network/NN
./.
====================
Keywords/NNS
:/:
genetic/JJ
network/NN
,/,
expression/NN
quantitative/JJ
trait/NN
,/,
linkage/NN
analysis/NN
,/,
metabolic/JJ
syndromeThe/DT
genetics/NNS
of/IN
complex/NN
diseases/NNS
is/VBZ
a/DT
continuous/JJ
challenge/NN
in/IN
human/JJ
genetic/JJ
studies/NNS
and/CC
chronic/JJ
disease/NN
epidemiology/NN
due/JJ
to/TO
the/DT
complexity/NN
of/IN
its/PRP$
biological/JJ
implications/NNS
./.
====================
Metabolic/JJ
syndrome/NN
,/,
which/WDT
is/VBZ
diverse/JJ
in/IN
pathology/NN
and/CC
considered/VBN
to/TO
be/VB
a/DT
growing/VBG
health/NN
problem/NN
,/,
consists/VBZ
of/IN
a/DT
cluster/NN
of/IN
endocrinemetabolic/JJ
disorders/NNS
,/,
such/JJ
as/IN
hypertension/NN
,/,
dyslipidemia/NN
,/,
glucose/NN
intolerance/NN
,/,
and/CC
abdominal/JJ
obesity/NN
(/(
Reaven/JJ
,/,
2002/CD
)/)
./.
====================
Insulin/RB
resistance/NN
has/VBZ
been/VBN
considered/VBN
an/DT
underlying/VBG
risk/NN
factor/NN
of/IN
these/DT
endocrine/JJ
disorders/NNS
(/(
Reaven/JJ
,/,
1988/CD
)/)
,/,
and/CC
its/PRP$
pathological/JJ
or/CC
epidemiological/JJ
characteristics/NNS
have/VBP
been/VBN
continually/RB
investigated/VBD
,/,
including/VBG
its/PRP$
genetic/JJ
aspects/NNS
./.
====================
Genetic/JJ
studies/NNS
on/IN
metabolic/JJ
syndrome/NN
have/VBP
been/VBN
conducted/VBN
mostly/RB
using/VBG
the/DT
candidate/NN
gene/NN
approach/DT
,/,
with/IN
much/RB
success/RB
in/IN
identifying/VBG
its/PRP$
genetic/JJ
components/NNS
(/(
Bonnet/NNP
et/FW
al./FW
,/,
2008/CD
;/:
Groop/NNP
,/,
2000/CD
;/:
Horenstein/NNP
and/CC
Shuldiner/NN
,/,
2004/CD
;/:
Ma/NNP
et/FW
al./FW
,/,
2007/CD
;/:
Mercado/NNP
et/FW
al./FW
,/,
2002/CD
;/:
Sale/JJ
et/FW
al./FW
,/,
2006/CD
;/:
Stern/NNP
,/,
2003/CD
;/:
Vasseur/NNP
et/FW
al./FW
,/,
2006/CD
;/:
Wang/NNP
et/FW
al./FW
,/,
2004/CD
;/:
Yang/NNP
and/CC
Chuang/NNP
,/,
2006/CD
)/)
./.
====================
Some/DT
studies/NNS
have/VBP
focused/VBN
on/IN
the/DT
relationships/NNS
between/IN
components/NNS
of/IN
the/DT
metabolic/JJ
syndrome/NN
(/(
Kopf/NN
et/FW
al./FW
,/,
2008/CD
;/:
Mussig/NN
et/FW
al./FW
,/,
2009/CD
)/)
or/CC
among/IN
the/DT
candidate/NN
genes/NNS
that/WDT
are/VBP
related/JJ
to/TO
it/PRP
(/(
Foufelle/NN
and/CC
Ferre/JJ
,/,
2002/CD
)/)
./.
====================
However/RB
,/,
the/DT
mechanism/NN
that/WDT
underlies/VBZ
the/DT
interrelationships/NNS
between/IN
related/JJ
genes/NNS
has/VBZ
been/VBN
not/RB
fully/RB
determined/VBN
,/,
and/CC
although/IN
various/JJ
genes/NNS
contribute/VBP
to/TO
the/DT
disease/NN
,/,
the/DT
effect/NN
size/NN
of/IN
a/DT
single/JJ
gene/NN
is/VBZ
very/RB
weak/JJ
./.
====================
Understanding/VBG
genetic/JJ
components/NNS
represents/VBZ
a/DT
challenge/NN
in/IN
not/RB
only/RB
insulin/NN
resistance/NN
but/CC
also/RB
most/JJS
complex/NN
diseases/NNS
./.
====================
To/TO
unravel/VB
the/DT
underlying/VBG
genetic/JJ
mechanisms/NNS
for/IN
complex/NN
diseases/NNS
,/,
various/JJ
concepts/NNS
and/CC
methods/NNS
have/VBP
been/VBN
applied/VBN
,/,
such/JJ
as/IN
genenetwork/NN
(/(
Wessels/NNS
et/FW
al./FW
,/,
2001/CD
)/)
,/,
pathway/NN
analysis/NN
(/(
Yu/NNP
et/FW
al./FW
,/,
2009/CD
)/)
,/,
and/CC
generegulator/NN
approaches/NNS
(/(
de/FW
Jong/JJ
,/,
2002/CD
;/:
Hasty/NNP
et/FW
al./FW
,/,
2001/CD
)/)
./.
====================
Gene/NN
set/NN
approaches/NNS
,/,
such/JJ
as/IN
network/NN
modeling/VBG
,/,
can/MD
be/VB
utilized/VBN
when/WRB
information/NN
on/IN
the/DT
genetic/JJ
pathway/NN
is/VBZ
lacking/VBG
./.
====================
Various/JJ
studies/NNS
have/VBP
contributed/VBN
to/TO
determining/VBG
gene/NN
gene/NN
interactions/NNS
by/IN
constructing/VBG
gene/NN
network/NN
models/NNS
using/VBG
several/JJ
statistical/JJ
approaches/NNS
(/(
Markou/NNP
and/CC
Singh/JJ
,/,
2003a/CD
)/)
./.
====================
Some/DT
studies/NNS
have/VBP
applied/VBN
computational/JJ
methods/NNS
,/,
such/JJ
as/IN
neural/JJ
network/NN
models/NNS
(/(
Markou/NNP
and/CC
Singh/JJ
,/,
2003b/NN
;/:
Vohradsky/NNP
,/,
2001/CD
)/)
./.
====================
Gene/NN
network/NN
models/NNS
that/DT
are/VBP
based/VBN
on/IN
statistical/JJ
and/CC
computational/JJ
approaches/NNS
have/VBP
been/VBN
helpful/JJ
in/IN
detecting/VBG
the/DT
``/NN
lines/NNS
''/``
of/IN
genegene/NN
interactions/NNS
./.
====================
However/RB
,/,
exploring/VBG
the/DT
biological/JJ
or/CC
functional/JJ
directions/NNS
of/IN
network/NN
lines/NNS
still/RB
remains/VBZ
a/DT
challenge/NN
,/,
be/VB
cause/VBN
the/DT
biological/JJ
implication/NN
of/IN
these/DT
models/NNS
has/VBZ
mostly/RB
been/VBN
unconsidered/JJ
and/CC
because/IN
interpreting/VBG
the/DT
metabolic/JJ
pathway/NN
among/IN
the/DT
networked/JJ
genes/NNS
can/MD
be/VB
difficult/JJ
./.
====================
The/DT
biological/JJ
aspect/NN
of/IN
diseaserelated/JJ
metabolites/NNS
must/MD
be/VB
taken/VBN
into/IN
account/VBP
due/JJ
to/TO
its/PRP$
importance/NN
in/IN
understanding/VBG
gene-gene/NN
interactions/NNS
./.
====================
A/DT
clear/JJ
example/NN
can/MD
be/VB
seen/VBN
in/IN
the/DT
components/NNS
of/IN
metabolic/JJ
syndrome/NN
,/,
such/JJ
as/IN
insulin/NN
,/,
lipid/NN
,/,
glucose/NN
,/,
and/CC
adiponectin/NN
,/,
which/WDT
interact/VBP
with/IN
each/DT
other/JJ
./.
====================
Glucose/NN
metabolism/NN
interacts/VBZ
with/IN
lipid/NN
metabolism/NN
via/IN
the/DT
central/JJ
nervous/JJ
system/NN
(/(
Schulingkamp/NNP
et/FW
al./FW
,/,
2000/CD
)/)
./.
====================
The/DT
insulin/NN
pathway/NN
is/VBZ
associated/VBN
with/IN
adipose/JJ
metabolism/NN
,/,
which/WDT
is/VBZ
evident/JJ
in/IN
certain/JJ
disorders/NNS
,/,
such/JJ
as/IN
fatty/JJ
liver/NN
disease/NN
(/(
Bouzakri/NNP
et/FW
al./FW
,/,
2006/CD
;/:
Kantartzis/NNP
et/FW
al./FW
,/,
2009/CD
;/:
Previs/NNP
et/FW
al./FW
,/,
2000/CD
)/)
./.
====================
The/DT
challenges/NNS
,/,
nonetheless/JJ
,/,
are/VBP
in/IN
detecting/VBG
the/DT
interactions/NNS
and/CC
effects/NNS
of/IN
genes/NNS
on/IN
each/DT
other/JJ
./.
====================
To/TO
solve/VB
this/DT
problem/NN
,/,
some/DT
studies/NNS
have/VBP
suggested/VBN
the/DT
concept/NN
of/IN
a/DT
causal/JJ
network/NN
,/,
which/WDT
consists/VBZ
of/IN
biological/JJ
functions/NNS
and/CC
implications/NNS
in/IN
the/DT
gene/NN
network/NN
construction/NN
(/(
Schadt/NNP
and/CC
Lum/NN
,/,
2006/CD
)/)
./.
====================
This/DT
approach/NN
has/VBZ
been/VBN
useful/JJ
in/IN
clarifying/VBG
how/WRB
genetic/JJ
networks/NNS
intervene/NN
in/IN
the/DT
biological/JJ
pathway/NN
of/IN
animal/JJ
populations/NNS
(/(
Kulp/NN
and/CC
Jagalur/NN
,/,
2006/CD
;/:
Schadt/NNP
et/FW
al./FW
,/,
2005/CD
;/:
Tu/NNP
et/FW
al./FW
,/,
2006/CD
)/)
./.
====================
In/IN
humans/NNS
,/,
however/RB
,/,
the/DT
causal/JJ
genetic/JJ
network/NN
remains/VBZ
a/DT
challenge/NN
because/IN
of/IN
its/PRP$
complexity/NN
and/CC
numerous/JJ
associated/VBN
factors/NNS
,/,
including/VBG
environmental/JJ
and/CC
behavioral/JJ
variables/NNS
./.
====================
In/IN
this/DT
study/NN
,/,
we/PRP
demonstrated/VBD
a/DT
simple/JJ
,/,
intuitive/JJ
method/NN
of/IN
constructing/VBG
a/DT
directed/JJ
causal/JJ
network/NN
with/IN
an/DT
expression/NN
quantitative/JJ
trait/NN
(/(
eQT/NN
)/)
that/WDT
is/VBZ
related/JJ
to/TO
metabolic/JJ
syndrome/NN
./.
====================
We/PRP
aimed/VBD
to/TO
explore/VB
the/DT
direction/JJ
that/DT
supported/VBD
the/DT
biological/JJ
function/NN
of/IN
the/DT
eQTs/NNS
and/CC
not/RB
base/NN
our/PRP$
interpretation/NN
solely/RB
on/IN
statistical/JJ
significance/NN
./.
====================
To/TO
identify/VB
the/DT
direction/NN
,/,
we/PRP
used/VBD
information/NN
from/IN
the/DT
peak/NN
loci/NNS
of/IN
each/DT
eQT/NN
via/IN
variance/NN
component/NN
linkage/NN
analysis/NN
./.
====================
The/DT
use/NN
of/IN
these/DT
eQTs/NNS
,/,
which/WDT
was/VBD
obtained/VBN
during/IN
mRNA/NN
transcription/NN
,/,
can/MD
be/VB
helpful/JJ
in/IN
identifying/VBG
the/DT
genetic/JJ
components/NNS
that/IN
are/VBP
associated/VBN
with/IN
disease/NN
(/(
Rockman/NNP
and/CC
Kruglyak/JJ
,/,
2006/CD
)/)
./.
====================
In/IN
the/DT
Materials/NNS
and/CC
Methods/NNS
section/NN
,/,
we/PRP
describe/VBP
the/DT
data/NNS
that/WDT
we/PRP
obtained/VBD
and/CC
the/DT
eQT/NN
selection/NN
criteria/NNS
./.
====================
The/DT
methodology/NN
of/IN
constructing/VBG
the/DT
directed/VBN
gene/NN
network/NN
modelvia/NN
linkage/NN
analysis/NN
is/VBZ
also/RB
referred/VBN
to/TO
in/IN
this/DT
section/NN
./.
====================
In/IN
the/DT
Results/NNS
section/NN
,/,
we/PRP
present/VBP
the/DT
linkage/NN
peak/NN
loci/NNS
and/CC
logarithm/NN
of/IN
the/DT
odds/NNS
(/(
base/NN
10/CD
)/)
(/(
LOD/NN
)/)
scores/VBZ
of/IN
important/JJ
eQTs/NNS
./.
====================
We/PRP
also/RB
describe/VBP
the/DT
gene/NN
network/NN
model/NN
that/DT
is/VBZ
associated/VBN
with/IN
metabolic/JJ
syndrome/NN
by/IN
matching/VBG
the/DT
peak/NN
loci/NNS
and/CC
several/JJ
specific/JJ
genes/NNS
./.
====================
In/IN
the/DT
Discussion/NN
section/NN
,/,
we/PRP
show/VBP
the/DT
biological/JJ
implication/NN
of/IN
our/PRP$
results/NNS
with/IN
an/DT
inquiry/JJ
into/IN
our/PRP$
methodology/NN
of/IN
gene/NN
network/NN
construction/NN
./.
====================
Data/NNS
were/VBD
obtained/VBN
from/IN
Problem/NN
1/CD
(/(
Genetics/NNS
of/IN
Gene/NN
Expression/NN
Variation/NN
in/IN
Humans/JJ
)/)
of/IN
the/DT
15th/NN
Genetic/JJ
Analysis/NN
Workshop/NNP
(/(
GAW15/NN
)/)
and/CC
contained/VBD
194/CD
individuals/NNS
in/IN
14/CD
3generation/NN
Centre/NNP
d'Etude/VBP
du/IN
Polymorphisme/NN
Humain/NNP
(/(
CEPH/NN
)/)
Utah/NNP
families/NNS
(/(
Cheung/NNP
and/CC
Spielman/JJ
,/,
2007/CD
;/:
Morley/NNP
et/FW
al./FW
,/,
2004/CD
)/)
./.
====================
The/DT
expression/NN
levels/NNS
of/IN
3554/CD
genes/NNS
in/IN
lymphoblastic/JJ
cells/NNS
were/VBD
analyzed/VBN
as/IN
phenotypes/NNS
./.
====================
From/IN
these/DT
genes/NNS
,/,
we/PRP
selected/VBD
49/CD
eQTs/NNS
that/DT
are/VBP
known/VBN
to/TO
be/VB
associated/VBN
with/IN
insulin/NN
resistance/NN
,/,
based/VBN
on/IN
previous/JJ
studies/NNS
and/CC
gene/NN
databases/NNS
./.
====================
The/DT
basic/JJ
characteristics/NNS
of/IN
the/DT
selected/VBN
eQTs/NNS
are/VBP
presented/VBN
in/IN
Table/JJ
1/CD
./.
====================
The/DT
genotype/NN
data/NNS
were/VBD
collected/VBN
for/IN
2884/CD
single/JJ
nucleotide/NN
polymorphism/NN
(/(
SNP/NN
)/)
markers/NNS
across/IN
22/CD
autosomal/JJ
chromosomes/NNS
and/CC
the/DT
Xlinked/JJ
chromosome/NN
from/IN
194/CD
individuals/NNS
./.
====================
Sexaveraged/JJ
Rutgers/NNS
Combined/JJ
Linkage/JJ
Physical/JJ
Map/NN
(/(
Matise/JJ
et/FW
al./FW
,/,
2007/CD
)/)
was/VBD
matched/VBN
with/IN
the/DT
original/JJ
map/VBP
file/JJ
to/TO
account/VB
for/IN
the/DT
recombination/NN
fraction/NN
of/IN
given/VBN
SNP/NN
markers/NNS
./.
====================
For/IN
each/DT
of/IN
the/DT
49/CD
metabolic/JJ
syndromerelated/JJ
eQTs/NNS
,/,
variance/NN
component/NN
linkage/NN
analysis/NN
,/,
which/WDT
is/VBZ
commonly/RB
used/VBN
for/IN
mapping/VBG
quantitative/JJ
trait/NN
loci/NNS
,/,
was/VBD
performed/VBN
to/TO
search/VB
the/DT
genomic/JJ
loci/NNS
with/IN
a/DT
linkage/NN
peak/NN
across/IN
22/CD
autosomal/JJ
chromosomes/NNS
./.
====================
Note/RB
that/DT
the/DT
Xlinked/JJ
23rd/JJ
chromosome/NN
was/VBD
excluded/VBN
from/IN
the/DT
investigation/NN
./.
====================
The/DT
linkage/NN
peak/NN
loci/NNS
were/VBD
investigated/VBN
,/,
and/CC
the/DT
``/NN
support/VBP
zone/NN
''/CD
was/VBD
defined/VBN
within/IN
the/DT
bounds/NNS
up/IN
to/TO
an/DT
LOD/NN
score/RB
of/IN
0.5/CD
from/IN
the/DT
peak/NN
./.
====================
Fig/NN
./.
====================
1/CD
represents/VBZ
an/DT
example/NN
of/IN
a/DT
linkage/NN
peak/NN
point/NN
and/CC
support/VBP
zone/NN
identification/NN
with/IN
an/DT
eQT/NN
of/IN
the/DT
IRS2/NN
gene/NN
./.
====================
To/TO
explore/VB
genegene/NN
interactions/NNS
,/,
we/PRP
studied/VBD
the/DT
relationships/NNS
between/IN
all/DT
possible/JJ
pairs/NNS
of/IN
the/DT
49/CD
genes/NNS
./.
====================
We/PRP
investigated/VBD
whether/IN
SNP/NN
markers/NNS
,/,
which/WDT
are/VBP
located/JJ
on/IN
the/DT
linkage/NN
peak/NN
,/,
were/VBD
found/VBN
in/IN
several/JJ
specific/JJ
genes/NNS
./.
====================
If/IN
one/CD
gene/NN
was/VBD
located/JJ
within/IN
the/DT
``/JJ
support/VBP
zone/NN
''/RB
of/IN
the/DT
peak/NN
loci/NNS
for/IN
the/DT
eQT/JJ
of/IN
another/DT
gene/NN
,/,
the/DT
relationship/NN
was/VBD
considered/VBN
as/IN
a/DT
potential/JJ
``/JJ
directed/VBN
causal/JJ
pathway/NN
''/NNP
from/IN
the/DT
former/JJ
to/TO
the/DT
latter/JJ
gene/NN
,/,
according/VBG
to/TO
the/DT
following/VBG
logic/JJ
;/:
if/IN
there/EX
is/VBZ
a/DT
linkage/NN
between/IN
eQT/JJ
as/IN
a/DT
phenotype/NN
and/CC
a/DT
genetic/JJ
locus/NN
,/,
the/DT
causal/JJ
direction/JJ
can/MD
be/VB
assumed/VBN
to/TO
be/VB
from/IN
the/DT
gene/NN
to/TO
the/DT
phenotype/NN
,/,
rather/RB
than/IN
the/DT
opposite/JJ
direction/JJ
./.
====================
Since/IN
a/DT
particular/JJ
eQT/NN
represents/VBZ
the/DT
function/NN
of/IN
the/DT
underlying/VBG
gene/NN
(/(
e./FW
g./FW
,/,
A/DT
)/)
,/,
the/DT
greatest/JJS
linkage/NN
signal/NN
is/VBZ
observed/VBN
on/IN
the/DT
locus/NN
of/IN
A/DT
./.
====================
In/IN
addition/NN
,/,
if/IN
the/DT
eQT/JJ
for/IN
A/DT
is/VBZ
also/RB
linked/VBN
with/IN
another/DT
gene/NN
B/NN
,/,
this/DT
linkage/NN
also/RB
implies/VBZ
a/DT
causal/JJ
direction/JJ
from/IN
gene/NN
B/NN
to/TO
the/DT
eQT/JJ
phenotype/NN
,/,
which/WDT
suggests/VBZ
a/DT
causal/JJ
connection/NN
from/IN
gene/NN
B/NN
to/TO
gene/NN
A/DT
,/,
which/WDT
underlies/VBZ
the/DT
eQT/JJ
./.
====================
Genes/NNS
from/IN
the/DT
49/CD
selected/VBN
eQTs/NNS
were/VBD
preferentially/RB
included/VBD
in/IN
the/DT
metabolic/JJ
syndrome-related/JJ
gene/NN
network/NN
model/NN
due/JJ
to/TO
their/PRP$
association/NN
with/IN
the/DT
mechanisms/NNS
of/IN
the/DT
disease/NN
./.
====================
Other/JJ
genes/NNS
,/,
which/WDT
were/VBD
identified/VBN
with/IN
SNP/NN
markers/NNS
in/IN
the/DT
support/NN
zone/NN
,/,
were/VBD
also/RB
added/VBN
in/IN
the/DT
directed/JJ
network/NN
model/NN
./.
====================
Merlin/NN
1.1.2/CD
software/JJ
was/VBD
used/VBN
for/IN
the/DT
variance/NN
component/NN
linkage/NN
analysis/NN
./.
====================
To/TO
identify/VB
the/DT
network/NN
model/NN
of/IN
the/DT
gene/NN
expression/NN
levels/NNS
that/IN
were/VBD
related/JJ
to/TO
metabolic/JJ
syndrome/NN
,/,
variance/NN
component/NN
linkage/NN
analyses/NNS
were/VBD
performed/VBN
individually/RB
with/IN
the/DT
49/CD
selected/VBN
eQTs/NNS
./.
====================
Table/JJ
2/CD
represents/VBZ
the/DT
LOD/NN
scores/VBZ
and/CC
linkage/NN
peak/NN
loci/NNS
of/IN
14/CD
eQTs/NNS
./.
====================
We/PRP
identified/VBD
about/IN
14/CD
linkage/NN
peaks/VBZ
with/IN
LOD/NN
scores/VBZ
＞2.0/CD
for/IN
eQTs/NNS
,/,
with/IN
6/CD
of/IN
these/DT
eQTs/NNS
displaying/VBG
LOD/NN
scores/VBZ
＞2.5/CD
./.
====================
For/IN
the/DT
genes/NNS
ADFP/NN
and/CC
IRS2/NN
,/,
the/DT
highest/JJS
LOD/NN
scores/VBZ
of/IN
3.09/CD
and/CC
3.08/CD
were/VBD
observed/VBN
at/IN
SNPs/NNS
on/IN
chromosomes/NNS
5/CD
and/CC
2/CD
,/,
respectively/RB
./.
====================
To/TO
explore/VB
genegene/NN
interactions/NNS
,/,
we/PRP
investigated/VBD
whether/IN
the/DT
SNP/NN
markers/NNS
on/IN
the/DT
linkage/NN
peak/NN
or/CC
in/IN
the/DT
``/NN
support/VBP
zone/NN
''/CD
were/VBD
included/VBN
in/IN
several/JJ
specific/JJ
genes/NNS
./.
====================
The/DT
results/NNS
showed/VBD
that/IN
several/JJ
SNP/NN
markers/NNS
colocalized/VBD
within/IN
these/DT
genes/NNS
./.
====================
Since/IN
we/PRP
used/VBD
a/DT
small/JJ
SNP/NN
marker/NN
set/NN
,/,
we/PRP
considered/VBD
that/IN
the/DT
49/CD
selected/VBN
eQTs/NNS
might/MD
not/RB
have/VB
been/VBN
identified/VBN
with/IN
the/DT
linkage/NN
analysis/NN
./.
====================
Therefore/RB
,/,
we/PRP
searched/VBD
the/DT
location/NN
of/IN
each/DT
selected/VBN
eQT/JJ
in/IN
the/DT
NCBI/NN
gene/NN
database/NN
to/TO
determine/VB
whether/IN
the/DT
location/NN
of/IN
each/DT
eQT/NN
coincided/VBD
with/IN
the/DT
linkage/NN
peak/NN
./.
====================
Tables/NNS
3/CD
and/CC
4/CD
show/VBP
the/DT
relationship/NN
between/IN
genes/NNS
pairs/NNS
with/IN
LOD/NN
scores/VBZ
of/IN
＞2.0/CD
./.
====================
Eight/CD
genes/NNS
,/,
LRRIQ1/NN
,/,
APOL3/NN
,/,
APOL4/NN
,/,
IGSF4/NN
,/,
ASTN2/NN
,/,
NRP1/NN
,/,
SFXN1/NN
,/,
and/CC
ASCL3/NN
,/,
were/VBD
located/JJ
on/IN
the/DT
peak/NN
of/IN
eQTs/NNS
,/,
known/VBN
as/IN
IGF1/NN
,/,
UGCGL2/NN
,/,
IDE/NN
,/,
BCL2/NN
,/,
BCAP29/NN
,/,
VEGFB/NN
,/,
PTPN6/NN
,/,
and/CC
APOBEC3B/NN
,/,
respectively/RB
./.
====================
Thirty-one/DT
genes/NNS
were/VBD
located/JJ
in/IN
the/DT
support/NN
zone/NN
./.
====================
Among/IN
the/DT
total/JJ
39/CD
genes/NNS
at/IN
both/CC
the/DT
peak/NN
point/NN
and/CC
support/VBP
zone/NN
,/,
7/CD
genes/NNS
,/,
known/VBN
as/IN
APOL3/NN
,/,
IGFBP2/NN
,/,
BTG1/NN
,/,
UGCGL2/NN
,/,
LEPR/NN
,/,
APOL6/NN
,/,
and/CC
IRS2/NN
,/,
were/VBD
included/VBN
in/IN
the/DT
49/CD
selected/VBN
eQTs/NNS
./.
====================
The/DT
gene/NN
network/NN
was/VBD
constructed/VBN
with/IN
the/DT
selected/VBN
eQTs/NNS
,/,
from/IN
which/WDT
two/CD
groups/NNS
of/IN
gene/NN
networks/NNS
were/VBD
formed/VBN
,/,
each/DT
around/IN
the/DT
genes/NNS
IRS2/NN
and/CC
UGCGL2/NN
(/(
Fig/NN
./.
====================
2/CD
)/)
./.
====================
IRS2/NN
was/VBD
grouped/VBN
with/IN
6/CD
genes/NNS
,/,
APOBEC3B/NN
,/,
BTG1/NN
,/,
HDLBP/NN
,/,
IDE/NN
,/,
IGF1/NN
,/,
and/CC
IGFBP2/NN
./.
====================
To/TO
explore/VB
the/DT
biological/JJ
network/NN
,/,
the/DT
functions/NNS
of/IN
each/DT
gene/NN
were/VBD
searched/VBN
via/IN
the/DT
NCBI/NN
gene/NN
database/NN
./.
====================
The/DT
IRS2/NN
gene/NN
,/,
which/WDT
belongs/VBZ
to/TO
an/DT
insulin/NN
receptor/NN
substrate/NN
family/NN
,/,
is/VBZ
known/VBN
to/TO
play/VB
a/DT
role/NN
in/IN
the/DT
insulin/NN
signaling/NN
pathway/NN
./.
====================
The/DT
cogrouped/JJ
genes/NNS
were/VBD
also/RB
related/JJ
to/TO
insulin/NN
metabolism/NN
./.
====================
We/PRP
found/VBD
a/DT
stream/JJ
from/IN
IGFBP2/NN
to/TO
IDE/NN
,/,
which/WDT
consisted/VBD
completely/RB
of/IN
genes/NNS
that/WDT
play/VBP
a/DT
role/NN
in/IN
insulin/NN
metabolism/NN
./.
====================
The/DT
UGCGL2/NN
gene/NN
is/VBZ
known/VBN
to/TO
transfer/VB
glycosyl/NN
groups/NNS
(/(
Arnold/NN
and/CC
Kaufman/JJ
,/,
2003/CD
)/)
./.
====================
It/PRP
showed/VBD
a/DT
directed/JJ
network/NN
with/IN
4/CD
genes/NNS
,/,
known/VBN
as/IN
APOL3/NN
,/,
APOL6/NN
,/,
LEPR/NN
,/,
and/CC
UGP2/NN
./.
====================
This/DT
grouped/VBD
network/NN
showed/VBD
a/DT
pathway/NN
of/IN
adipose/NN
,/,
lipid/NN
,/,
and/CC
glucose/NN
metabolites/NNS
./.
====================
LEPR/NN
,/,
the/DT
leptin/NN
receptor/NN
,/,
is/VBZ
known/VBN
to/TO
be/VB
related/JJ
to/TO
adipose/VB
tissue/NN
mass/NN
regulation/NN
(/(
Kershaw/NN
and/CC
Flier/NN
,/,
2004/CD
;/:
Ronti/NNP
et/FW
al./FW
,/,
2006/CD
)/)
./.
====================
APOL3/NN
and/CC
APOL6/NN
both/CC
play/VBP
a/DT
role/NN
in/IN
lipid/NN
metabolism/NN
,/,
in/IN
lipid/NN
transportation/NN
and/CC
lipid/NN
binding/NN
,/,
respectively/RB
./.
====================
UGP2/NN
,/,
which/WDT
was/VBD
identified/VBN
as/IN
being/VBG
influenced/VBN
by/IN
UGCGL2/NN
in/IN
our/PRP$
study/NN
,/,
undertakes/VBZ
glucose/NN
transfer/NN
,/,
especially/RB
in/IN
liver/NN
and/CC
muscle/NN
tissues/NNS
./.
====================
The/DT
shape/NN
of/IN
the/DT
gene/NN
network/NN
between/IN
the/DT
two/CD
groups/NNS
is/VBZ
distinct/JJ
./.
====================
The/DT
network/NN
around/IN
the/DT
IRS2/NN
gene/NN
displays/VBZ
a/DT
flow/NN
of/IN
the/DT
insulin/NN
pathway/NN
./.
====================
However/RB
,/,
in/IN
the/DT
second/JJ
group/NN
surrounding/VBG
the/DT
UGCGL2/NN
gene/NN
,/,
3/CD
of/IN
the/DT
other/JJ
genes/NNS
that/WDT
were/VBD
identified/VBN
influence/VBP
UGCGL2/NN
./.
====================
According/VBG
to/TO
these/DT
results/NNS
,/,
we/PRP
can/MD
propose/VB
that/IN
IRS2/NN
plays/VBZ
a/DT
role/NN
as/IN
an/DT
intermediator/NN
in/IN
the/DT
insulin/NN
metabolism/NN
pathway/NN
and/CC
that/IN
UGCGL2/NN
appears/VBZ
to/TO
be/VB
at/IN
the/DT
center/NN
of/IN
the/DT
lipid/NN
and/CC
glucose/NN
metabolism/NN
pathway/NN
./.
====================
In/IN
this/DT
study/NN
,/,
we/PRP
aimed/VBD
to/TO
construct/VB
a/DT
directed/JJ
gene/NN
network/NN
that/DT
was/VBD
related/JJ
to/TO
metabolic/JJ
syndrome/NN
via/IN
comparison/NN
of/IN
the/DT
linkage/NN
peak/NN
loci/NNS
and/CC
LOD/NN
scores/VBZ
of/IN
selected/VBN
eQTs/NNS
./.
====================
Since/IN
the/DT
genetics/NNS
of/IN
metabolic/JJ
syndrome/NN
is/VBZ
polygenic/JJ
and/CC
heterogeneous/JJ
(/(
Mercado/NNP
et/FW
al./FW
,/,
2002/CD
)/)
,/,
the/DT
gene/NN
set/NN
approach/NN
that/IN
we/PRP
have/VBP
presented/VBN
in/IN
this/DT
study/NN
can/MD
be/VB
helpful/JJ
in/IN
understanding/VBG
the/DT
genetic/JJ
components/NNS
of/IN
the/DT
disease/NN
./.
====================
We/PRP
explored/VBD
the/DT
direction/NN
that/DT
supported/VBD
the/DT
biological/JJ
gene/NN
function/NN
./.
====================
Two/CD
groups/NNS
of/IN
gene/NN
networks/NNS
were/VBD
constructed/VBN
,/,
each/DT
surrounding/VBG
the/DT
genes/NNS
IRS2/NN
and/CC
UGCGL2/NN
./.
====================
The/DT
former/JJ
networking/VBG
group/NN
showed/VBD
the/DT
pathway/NN
that/WDT
was/VBD
related/JJ
to/TO
insulin/NN
metabolism/NN
,/,
and/CC
the/DT
latter/JJ
represented/VBN
lipid/NN
and/CC
glucose/NN
metabolism/NN
./.
====================
We/PRP
identified/VBD
the/DT
direction/JJ
among/IN
genegene/NN
interactions/NNS
,/,
and/CC
several/JJ
genes/NNS
could/MD
be/VB
supported/VBN
with/IN
known/VBN
biological/JJ
pathways/NNS
,/,
reported/VBD
in/IN
previous/JJ
studies/NNS
./.
====================
For/IN
example/NN
,/,
the/DT
BTG1/NN
gene/NN
was/VBD
identified/VBN
in/IN
our/PRP$
study/NN
as/IN
belonging/VBG
to/TO
a/DT
group/NN
that/IN
was/VBD
surrounded/VBN
with/IN
IRS2/NN
,/,
which/WDT
belongs/VBZ
to/TO
a/DT
family/NN
of/IN
insulin/NN
receptor/NN
substrate/NN
proteins/NNS
(/(
Saltiel/NN
and/CC
Kahn/NN
,/,
2001/CD
)/)
./.
====================
It/PRP
supports/VBZ
the/DT
known/JJ
biological/JJ
correlation/NN
that/IN
gene/NN
expression/NN
of/IN
BTG1/NN
is/VBZ
regulated/VBN
by/IN
insulin/NN
(/(
Kuiperij/NNP
,/,
2004/CD
)/)
./.
====================
Insulin/RB
also/RB
plays/VBZ
a/DT
role/NN
in/IN
the/DT
insulin-like/JJ
growth/NN
factor-binding/VBG
protein/NN
(/(
IGFBP/NN
)/)
system/NN
(/(
Kelley/NNP
et/FW
al./FW
,/,
1996/CD
)/)
,/,
as/IN
shown/VBN
in/IN
the/DT
relationship/NN
between/IN
IRS2/NN
and/CC
IGFBP2/NN
in/IN
the/DT
present/JJ
study/NN
./.
====================
Also/RB
,/,
we/PRP
could/MD
find/VB
the/DT
IGF1/NN
and/CC
IRS2/NN
genes/NNS
in/IN
the/DT
same/JJ
network/NN
in/IN
this/DT
study/NN
,/,
which/WDT
could/MD
be/VB
supported/VBN
by/IN
a/DT
previous/JJ
report/NN
that/IN
demonstrated/VBD
that/IN
a/DT
decrease/NN
in/IN
IGF1/NN
causes/VBZ
the/DT
degradation/NN
of/IN
IRS2/NN
(/(
Rui/NNP
et/FW
al./FW
,/,
2001/CD
)/)
./.
====================
We/PRP
also/RB
found/VBD
studies/NNS
that/IN
support/VBP
our/PRP$
results/NNS
regarding/VBG
the/DT
second/JJ
group/NN
(/(
e./FW
g./FW
,/,
leptin/NN
is/VBZ
associated/VBN
with/IN
glucose/NN
levels/NNS
)/)
(/(
Schwartz/NNP
et/FW
al./FW
,/,
1996/CD
)/)
./.
====================
According/VBG
to/TO
our/PRP$
results/NNS
,/,
the/DT
leptin/NN
receptor/NN
LEPR/NN
gene/NN
affects/VBZ
a/DT
glucose-related/JJ
gene/NN
,/,
UGCGL2/NN
./.
====================
Apolipoprotein-related/JJ
genes/NNS
,/,
such/JJ
as/IN
APOL3/NN
,/,
APOL4/NN
,/,
and/CC
APOL6/NN
,/,
in/IN
our/PRP$
gene/NN
network/NN
are/VBP
also/RB
associated/VBN
with/IN
glucose/NN
metabolism/NN
,/,
as/IN
suggested/VBD
by/IN
increased/VBN
apolipoprotein/NN
levels/NNS
in/IN
glucose-impaired/JJ
patients/NNS
(/(
Pietzsch/NN
et/FW
al./FW
,/,
1998/CD
)/)
./.
====================
Since/IN
the/DT
biological/JJ
correlation/NN
between/IN
endocrine/JJ
metabolic/JJ
components/NNS
remains/VBZ
undiscovered/JJ
,/,
we/PRP
could/MD
not/RB
confirm/VB
the/DT
relationship/NN
between/IN
all/DT
of/IN
the/DT
genes/NNS
in/IN
our/PRP$
network/NN
./.
====================
However/RB
,/,
our/PRP$
results/NNS
also/RB
support/VBP
the/DT
evidence/NN
of/IN
a/DT
gene/NN
network/NN
,/,
which/WDT
was/VBD
not/RB
based/VBN
solely/RB
on/IN
biological/JJ
evidence/NN
./.
====================
We/PRP
intended/VBD
to/TO
replicate/VB
our/PRP$
results/NNS
with/IN
a/DT
prior/JJ
gene/NN
network/NN
model/NN
,/,
which/WDT
included/VBD
gene/NN
function/NN
with/IN
the/DT
network/NN
construction/NN
(/(
Franke/JJ
et/FW
al./FW
,/,
2006/CD
)/)
./.
====================
A/DT
gene/NN
pathway/NN
previously/RB
known/VBN
via/IN
Franke/JJ
et/FW
al/JJ
./.
====================
was/VBD
found/VBN
in/IN
our/PRP$
study/NN
to/TO
have/VB
relatively/RB
simple/JJ
structure/NN
associated/VBN
with/IN
a/DT
higher/JJR
LOD/NN
score/RB
./.
====================
The/DT
network/NN
between/IN
the/DT
genes/NNS
ASCL/NN
and/CC
APOBEC3B/NN
(/(
LOD=2.46/CD
)/)
consists/VBZ
of/IN
only/RB
3/CD
genes/NNS
./.
====================
In/IN
contrast/NN
,/,
BTG1/NN
and/CC
IGF1/NN
(/(
LOD=1.5/CD
)/)
constitute/VBP
a/DT
more/RBR
complex/NN
network/NN
with/IN
12/CD
related/JJ
genes/NNS
(/(
Fig/NN
./.
====================
3/CD
)/)
./.
====================
We/PRP
can/MD
suppose/VB
that/DT
higher/JJR
LOD/NN
scores/VBZ
indicate/VBP
a/DT
stronger/JJR
effect/NN
on/IN
other/JJ
genes/NNS
and/CC
that/IN
their/PRP$
biological/JJ
pathway/NN
is/VBZ
more/RBR
directly/RB
associated/VBN
with/IN
each/DT
other/JJ
./.
====================
This/DT
study/NN
presents/VBZ
a/DT
robust/JJ
,/,
directed/VBN
causal/JJ
network/NN
construction/NN
via/IN
linkage/NN
analysis/NN
./.
====================
Linkage/JJ
analysis/NN
and/CC
eQTs/NNS
can/MD
be/VB
utilized/VBN
to/TO
explore/VB
genegene/NN
interaction/NN
mechanisms/NNS
,/,
including/VBG
their/PRP$
biological/JJ
implications/NNS
./.
====================
We/PRP
also/RB
anticipate/JJ
that/DT
our/PRP$
method/NN
will/MD
help/VB
overcome/VBP
the/DT
challenge/NN
of/IN
computational/JJ
complexity/NN
and/CC
the/DT
cost/JJ
of/IN
constructing/VBG
genetic/JJ
networks/NNS
(/(
Markou/NNP
and/CC
Singh/JJ
,/,
2003b/NN
;/:
Wessels/NNS
et/FW
al./FW
,/,
2001/CD
)/)
due/JJ
to/TO
the/DT
simplicity/JJ
of/IN
linkage/NN
analysis/NN
to/TO
identify/VB
gene/NN
expression/NN
loci/NNS
./.
====================
However/RB
,/,
this/DT
method/NN
of/IN
genetic/JJ
network/NN
construction/NN
has/VBZ
several/JJ
limitations/NNS
./.
====================
A/DT
linkage/NN
analysis/NN
with/IN
additional/JJ
SNP/NN
markers/NNS
,/,
which/WDT
will/MD
increase/VB
its/PRP$
density/NN
,/,
may/MD
generate/VB
more/RBR
accurate/JJ
LOD/NN
scores/VBZ
and/CC
increase/VBP
the/DT
linkage/NN
support/VBP
zone/NN
./.
====================
An/DT
analysis/NN
with/IN
more/RBR
eQTs/NNS
and/CC
oth/JJ
er/NN
criteria/NNS
to/TO
establish/VB
boundaries/NNS
of/IN
the/DT
``/NN
support/VBP
zone/NN
''/CD
can/MD
also/RB
affect/VB
the/DT
results/NNS
./.
====================
However/RB
,/,
in/IN
our/PRP$
study/NN
,/,
the/DT
support/NN
zone/NN
had/VBD
LOD/NN
scores/VBZ
＞1.7/CD
./.
====================
We/PRP
considered/VBD
this/DT
boundary/NN
to/TO
be/VB
acceptable/JJ
,/,
based/VBN
on/IN
an/DT
LOD/NN
score/RB
range/NN
of/IN
1.7-1.8/CD
,/,
which/WDT
has/VBZ
been/VBN
considered/VBN
potential/JJ
evidence/NN
of/IN
linkage/NN
among/IN
genes/NNS
(/(
Avery/RB
et/FW
al./FW
,/,
2004/CD
;/:
Comuzzie/NNP
et/FW
al./FW
,/,
2001/CD
;/:
Lindgren/NNP
et/FW
al./FW
,/,
2002/CD
;/:
Zhu/NNP
et/FW
al./FW
,/,
2002/CD
)/)
./.
====================
Despite/IN
these/DT
limitations/NNS
,/,
we/PRP
anticipate/VBP
that/DT
our/PRP$
study/NN
will/MD
contribute/VB
to/TO
the/DT
understanding/NN
of/IN
the/DT
genetic/JJ
components/NNS
that/IN
are/VBP
involved/VBN
in/IN
metabolic/JJ
syndrome/NN
./.
====================
Our/PRP$
methodology/NN
supports/VBZ
the/DT
characterization/NN
and/CC
location/NN
of/IN
eQTs/NNS
as/IN
an/DT
effective/JJ
approach/NN
for/IN
constructing/VBG
a/DT
genetic/JJ
network/NN
./.
====================
